glp-1 user GLP-1s: What They Are and How They Work 5 years ahead: How GLP-1

On average, people taking GLP-1 Treatments, Semaglutide or Tirzepatide eat about 30% less food than they would otherwise

These dual-action approaches (e.g., GLP-1R agonists + ActRII antibodies) hold great potential to reshape body composition more effectively

Thats nearly one-quarter of their body weight in a single yearresults close to what some people see after weight-loss surgery

She was a co-author on a recent paper, Utility of glucagon-like-peptide-1-receptor agonists in mast cell activation syndrome, which explored the effects GLP-1 agonists had on a case series of 47 patients with mast cell activation syndrome (MCAS)